Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Vertex Pharmaceuticals (NQ: VRTX ) 471.38 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Jun 20, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Vertex Pharmaceuticals < Previous 1 2 3 4 5 6 7 8 9 ... 43 44 Next > Earnings Preview: Vertex Pharmaceuticals February 02, 2024 Via Benzinga Should Quality Investors Include NASDAQ:VRTX in Their Portfolio? February 02, 2024 In this article we'll explore the quality characteristics of VERTEX PHARMACEUTICALS INC (NASDAQ:VRTX) Via Chartmill Top Stock Picks 2024: 3 Healthcare Stocks Leading Medical Advancements February 01, 2024 Discover how emerging tech is shaping healthcare stocks in 2024. See which companies are outperforming and what it means for your portfolio. Via InvestorPlace Biotech And Medtech Portfolio Notes On A Fed Day January 31, 2024 The Fed held rates keeping their future options flexible with no expectations for future cuts. The market did not like it and sold off with the Russell 2000 down 2.45% and the NASDAQ down 2.23% Via Talk Markets Topics Economy Exposures Interest Rates Buy Alert: 3 Stocks Sitting in the Sweet Spot January 31, 2024 They say timing is everything, so investors will want to take advantage of buying these stocks now instead of waiting. Via InvestorPlace Key Takeaways From Vertex Pharmaceuticals Analyst Ratings January 31, 2024 Via Benzinga Here's My Top Growth Stock to Buy Right Now January 27, 2024 There doesn't appear to be a weak link with this great stock. Via The Motley Fool Where Will Vertex Pharmaceuticals Be in 10 Years? January 25, 2024 As the adage goes, winners keep winning. Via The Motley Fool A Look Into Vertex Pharmaceuticals Inc's Price Over Earnings January 23, 2024 Via Benzinga Why Vertex Pharmaceuticals Stock Topped the Market Today January 30, 2024 The company reported that it met its primary endpoint in a study for its non-opioid pain drug. Via The Motley Fool Why Is Vertex Pharmaceuticals Stock Sliding Today? January 30, 2024 Explore Vertex Pharmaceuticals' Phase 3 results for VX-548, a NaV1.8 inhibitor, demonstrating significant pain relief post-surgery. Via Benzinga Vertex Skids — Its Alternative To Opioids Is 'Not A Game-Changer,' Says Analyst January 30, 2024 The company unveiled the results of Phase 3 testing in patients following a tummy tuck or bunion removal. Via Investor's Business Daily Is CRISPR Therapeutics a Buy in the New Bull Market? January 30, 2024 CRISPR Therapeutics is a specialist in the hot technology of gene editing. Via The Motley Fool AI, Biotech, Energy Sectors Expect M&A Revival For 2024 January 29, 2024 The AI market, along with energy and biotech, are ripe for M&A following the worst performance in almost a decade for deal-making in 2023. Via Benzinga Topics Artificial Intelligence Exposures Artificial Intelligence 3 Magnificent Stocks to Buy and Hold Forever January 27, 2024 Many investors will want to consider owning these stocks for a long time. Via The Motley Fool Could Sarepta Therapeutics Become the Next Vertex Pharmaceuticals? January 25, 2024 It's always tough to be compared to a giant. Via The Motley Fool Biotech Stocks Are on Fire: Here Are the Top 3 Picks for January January 25, 2024 These biotech stocks offer exciting and disruptive solutions with the potential to expand to market caps worth trillions. Via InvestorPlace Slow Market Penetration For Biogen's Another Alzheimer's Drug: UBS Highlights Risks, Forecasts January 24, 2024 UBS insights on Biogen Inc's challenges with Leqembi in the Alzheimer's market. Analyst downgrades, revised sales estimates, and CEO's growth strategy. Via Benzinga Where Will CRISPR Therapeutics Be in 5 Years? January 24, 2024 The company could maintain the momentum it gained last year. Via The Motley Fool Netflix To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Wednesday January 24, 2024 Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Via Benzinga 2 Super Stocks You'll Wish 5 Years From Now That You'd Bought Today January 24, 2024 These powerhouse stocks still have plenty of growth catalysts to tap into over the coming years. Via The Motley Fool 10 Health Care Stocks With Whale Alerts In Today's Session January 23, 2024 Via Benzinga 1 Setback and 1 Opportunity for CRISPR Therapeutics Stock January 23, 2024 Despite A bump in the road, the biotech's future looks sunny. Via The Motley Fool Momentum Shifts Back To Tech Stocks As Healthcare Lags In 2024 January 22, 2024 Small Cap traders are taking a break in 2024 as XBI is down 2.51% YTD. Via Talk Markets A New S&P 500 Bull Market Just Began: 3 No-Brainer Stocks to Buy Hand Over Fist January 22, 2024 These stocks seem likely to keep up their winning ways. Via The Motley Fool Topics Stocks Exposures US Equities 10 Health Care Stocks Whale Activity In Today's Session January 22, 2024 Via Benzinga Here's How Much $1000 Invested In Vertex Pharmaceuticals 10 Years Ago Would Be Worth Today January 22, 2024 Via Benzinga If You Invested $10,000 in Vertex Pharmaceuticals in 2018, This Is How Much You Would Have Today January 22, 2024 Has investing in Vertex been a better option than just putting your money in the S&P 500? Via The Motley Fool Topics Stocks Exposures US Equities Cathie Wood's Flagship ARKK ETF Is Taking On Water Due To Coinbase, Tesla, These Stocks January 22, 2024 The flagship ETF's top holdings are down in 2024, especially No. 1 Coinbase. Via Investor's Business Daily Topics ETFs 2 Smart Growth Stocks to Buy Hand Over Fist in 2024 January 21, 2024 These businesses are on paths to extremely bright futures. Via The Motley Fool < Previous 1 2 3 4 5 6 7 8 9 ... 43 44 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.